Organizational decisions of the analysis of senile comorbidity

  • Authors: Yakushin M.A.1,2, Vasilev M.D.1, Bakirova E.A.1, Vorobeva A.V.1, Karpova O.V.1, Kabaeva E.N.1, Zapovitryannaya A.A.1, Rubtsova N.I.1, Yakushina T.I.3
  • Affiliations:
    1. N. A. Semashko National Research Institute of Public Health
    2. Moscow State Regional University
    3. M.F. Vladimirsky Moscow Regional Research Clinical Institute,
  • Issue: No 3 (2023)
  • Section: Общественное здоровье и организация здравоохранения
  • URL: http://bulleten-nriph.ru/journal/article/view/2784
  • DOI: https://doi.org/10.25742/NRIPH.2023.03.019
  • Cite item

Abstract


Analysis of patterns of senile comorbidity formation was carried out. A key comorbid pathology platform was identified, which is the basis for the formation of the morbidity profile of patients of older age groups. Causal relationships between individual forms of key comorbid pathology have been systematized; afferent, efferent and docking pathology is structured. Organizational solutions are proposed to optimize the procedure for preventive inspection and dispensary observation of the population of various age groups.


About the authors

Mikhail A. Yakushin

N. A. Semashko National Research Institute of Public Health;
Moscow State Regional University

Author for correspondence.
Email: yakushinma@mail.ru

Russian Federation, 105064, Moscow, Russian Federation; Moscow, Russian Federation

Mikhail D. Vasilev

N. A. Semashko National Research Institute of Public Health

Email: m.vasilev@mail.ru
ORCID iD: 0000-0003-1646-7345

Russian Federation, 105064, Moscow, Russian Federation

Elsa A. Bakirova

N. A. Semashko National Research Institute of Public Health

Email: bealuk80@mail.ru

Russian Federation, 105064, Moscow, Russian Federation

Anna V. Vorobeva

N. A. Semashko National Research Institute of Public Health

Email: vorobievaanna2010@yandex.ru
ORCID iD: 0000-0003-4609-5343

Russian Federation, 105064, Moscow, Russian Federation

Olga V. Karpova

N. A. Semashko National Research Institute of Public Health

Email: dr/ovkarpova@yandex.ru
ORCID iD: 0000-0002-9466-219X

Russian Federation, 105064, Moscow, Russian Federation

Ekaterina N. Kabaeva

N. A. Semashko National Research Institute of Public Health

Email: katkab@list.ru
ORCID iD: 0000-0002-7941-2010

Russian Federation, 105064, Moscow, Russian Federation

Anastasia A. Zapovitryannaya

N. A. Semashko National Research Institute of Public Health

Email: noreply@nriph.ru
ORCID iD: 0000-0001-6718-704X

Russian Federation, 105064, Moscow, Russian Federation

Nadezda I. Rubtsova

N. A. Semashko National Research Institute of Public Health

Email: msk-nadezda@mail.ru
ORCID iD: 0000-0002-1472-7580

Russian Federation, 105064, Moscow, Russian Federation

Tatiana I. Yakushina

M.F. Vladimirsky Moscow Regional Research Clinical Institute,

Email: yakutanya@mail.ru

Russian Federation, Moscow, Russian Federation

References

  1. Sintsova A.P., Ponomareva M.N., Konovalova O.S. Polymorbidity in uncompensated glaucoma taking into account blood groups. University Medicine of the Urals. [Universitetskaja medicina Urala.] 2016;2(1):81—83 (in Russian).
  2. Drapkina O.M., Kim O.T., Dadaeva V.A. The history of obesity: from a symbol of fertility to a global public health problem. Preventive medicine. [Profilakticheskaja medicina]. 2021;24(1):98-103 (in Russian). doi: 10.17116/profmed20212401198
  3. Ismiev A.E., Shalenkov E.A. Eastern and Western medicine: a comparative analysis. Bulletin of Medical Internet Conferences. [Byulleten' meditsinskikh internet-konferentsiy]. 2015;5(12):1534 (in Russian).
  4. Vyatkin V.B. On the use of the term «syntropy» in scientific research. Scientific Review. Abstract journal. [Nauchnoe obozrenie. Referativnyj zhurnal]. 2016;(3):81—84 (in Russian).
  5. Alekseev S.A., Bordakov V.N. Surgical diseases: a textbook in parts. Part 2. Minsk; 2017. P.33 (in Russian).
  6. Fortin M., Bravo G., Hudon C., Vanasse A., Lapointe L. Prevalence of multimorbidity among adults seen in family practice. J. ann. fam. med. 2005;3(3):223—228. doi: 10.1370/afm.272
  7. Storch I., Sachar D., Katz S. Pulmonary Manifestations of Inflammatory Bowel Disease. J Inflamm. Bowel. Dis. 2003;9(2):104—115. doi: 10.1016/j.amjmed.2019.07.007
  8. Tagle M., Barriga J., Pineiro A. Advances in the physiology and management of hepatic encephalopathy. J. Rev. Gastroenterol. Peru. 2003;23(4):293—296.
  9. Zueva T.V., Zhdanova T.V., Urazlina S.E. Comorbidity of renal and cardiac pathology. Medical Bulletin of the North Caucasus. [Medicinskij vestnik Severnogo Kavkaza]. 2019;4(14):711—717 (in Russian). doi: 10.14300/mnnc.2019.14178
  10. Korzh A.N. Cardiorenal syndrome: clinical significance, diagnostic criteria, principles of therapy. Eastern European Journal of Internal and Family Medicine. [Vostochnoevropejskij zhurnal vnutrennej i semejnoj mediciny]. 2016;(6):36—42 (in Russian). doi: 10.15407/internalmed2016.02.036
  11. Zhuravleva L.V., Shekhovtsova Yu.A. Comorbidity of chronic pancreatitis and type 2 diabetes mellitus: possible pharmacotherapy options. A practicing doctor. [Praktikujushhij vrach]. 2016;5(3):21—25 (in Russian).
  12. Houghton A.M. Mechanistic links between COPD and lung cancer. J. Nat. Rev. Cancer. 2013;13(4):233—45. doi: 10.1038/nrc3477
  13. Inoue D., Watanabe R., Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int. J. Chron. Obstruct. Pulmon. Dis. 2016;(11):637—4. doi: 10.2147/COPD.S79638
  14. Savransky V., Nanayakkara A., Li J., Bevans S., Smith P.L., Rodriguez A., Polotsky V.Y. Chronic intermittent hypoxia induces atherosclerosis. Am. J. Respir. Crit. Care. Med. 2007;175(12):1290—1297. doi: 10.1164/rccm.200612-1771OC
  15. Gaddam S., Gunukula S.K., Lohr J.W., Arora P., Gaddam S., Gunukula S.K., Lohr J.W., Arora P. Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J. BMC Pulm. Med. 2016;16(1):158. doi: 10.1186/s12890-016-0315-0
  16. Murray MIK, Thalmann IN, Mossialos EA, Zeiher AM. Comorbidities of Coronary Heart Disease and the Impact on Healthcare Usage and Productivity Loss in a Nationally Based Study. J. Epidemiology (Sunnyvale). 2018;8(347): 2161—1165. doi: 10.4172/2161—1165.1000347
  17. Garcia-Olmos L, Salvador CH, Alberquilla A, et al. Comorbidity Patterns in Patients with Chronic Diseases in General Practice. J. PLoS ONE. 2012;7(2):32141. doi: 10.1371/journal.pone.0032141
  18. Kendir C, van den Akker M, Vos R, MetsemakersJ. Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands. Eur J Gen Pract. 2018;24(1):45—50. doi: 10.1080/13814788.2017.1398318
  19. Myasoedova EI, Schwarz YuG, Polunina OS, Voronina LP. Influence of concomitant chronic obstructive pulmonary disease on left ventricular-arterial interaction in patients with ischemic cardiomyopathy. J. Russian Journal of Cardiology. 2019;(2):38—43. doi: 10.15829/1560-4071-2019-2-38-43
  20. Tsaturova K.N., Dubakova A.S., Galkina E.A. Comorbid diseases in patients with type 2 diabetes mellitus. Bulletin of medical Internet conferences. [Bjulleten' medicinskih internet-konferencij]. 2017;7(5):747 (in Russian).
  21. Starostina E.G., Volodina M.N., Starostin I.V., Bobrov A.E. Depression and diabetes mellitus as comorbid diseases. RMJ. [RMZh]. 2017;25(22):1613—1620 (in Russian).
  22. Sokal J., Messias E., Dickerson F.B., Kreyenbuhl J., Brown C.H., Goldberg R.W. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J. Nerv. Ment. Dis. 2004;192(6):421. doi: 10.1097/01.nmd.0000130135.78017.96
  23. Petrova A.I., Tolkushkina O.V., Kislyak Z.V., Hirvonen M.V. Somatic comorbidity of patients of the psychiatric department of compulsory treatment. Omsk Psychiatric Journal. [Omskij psihiatricheskij zhurnal]. 2019;3(21):21—23 (in Russian).
  24. Verbenko V.A. Comorbidity of depressive spectrum disorders of chronic somatic diseases. The Tauride Journal of Psychiatry. [Tavricheskij zhurnal psihiatrii]. 2013;17(63):36—38 (in Russian).
  25. Andryushchenko A.V., Beskova D.A. Mental disorders in patients of the general somatic network (clinical and epidemiological aspects, psychosomatic relationships). Психиатрия. [Psihiatrija]. 2011;2(50):13—23 (in Russian).
  26. Robins D.L. How recognizing comorbidities in psychopathology may lead to ence an involved research nosology. J. Clinical Psychology: Science and Practice. 1994;(1):93—95. doi: 10.1111/j.1468—2850.1994.tb00010.x
  27. Tellez-Zenteno J.F., Matijevic S., Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. J. Epilepsia. 2005;46(12):1955. doi: 10.1111/j.1528—1167.2005.00344.x
  28. Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y, Li H, Singhal AB, WangY. Risk score to predict gastrointestinal bleeding after acute ischemic stroke. J. BMC Gastroenterol. 2014;14(1):1—9. doi: 10.1186/1471-230X-14-130
  29. Rylsky A.V. Comorbidity of acute cerebral circulatory disorders and diseases of the gastrointestinal tract. Ural Medical Journal. [Ural'skiy meditsinskiy zhurnal]. 2019;15(183):107—110 (in Russian).
  30. Kanyukov V.N. et al. Para-operative correction of somatic and psychosomatic pathology in ophthalmological practice. Orenburg; 2011. P.102 (in Russian).
  31. Kulmametov R.R., Pimenov A.A., Rakhmatullaev Sh.T., Novikova N.V. Polymorbidity in patients in need of cataract surgery. University Medicine of the Urals. [Universitetskaja medicina Urala].2017;3(8):35—36 (in Russian).
  32. Bakulev A.L. Psoriasis: clinical features, risk factors and associated comorbid conditions. Clinical pharmacology and therapy. [Klinicheskaja farmakologija i terapija]. 2019;28(1):35—39 (in Russian).
  33. Lazebnik Yu.B. Aging and polymorbidity. Consilium medicum. [Consilium medicum]. 2005;7(12):993—996 (in Russian).
  34. Seeger J.D., Kong S.X., Schumock G.T. Characteristics associated with ability to prevent adverse-drug reactions in hospitalized patients. J. Pharmacotherapy. 1998;18(6):1284—1289.
  35. Lazebnik L.B., Konev Yu.V., Efremov L.I. Polymorbidity in clinical practice: quantitative and qualitative assessment. Clinical gerontology. [Klinicheskaja gerontologija]. 2012;18(1—2):36—42 (in Russian).
  36. Lazebnik L.B., Konev Yu.V., Efremov L.I. Quantitative and qualitative assessment of comorbidity in geriatric practice. Experimental and clinical gastroenterology. [Jeksperimental'naja i klinicheskaja gastrojenterologija]. 2013;(9):3—8 (in Russian).
  37. Zhuravlev Yu.N., Thorikova V.N. Modern problems of polymorbidity measurement Scientific Bulletin of Belgorod State University: Medicine series. Pharmacy. [Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta: Serija Medicina. Farmacija].2013;11(154):214—219 (in Russian).
  38. Van den Akker M., Buntinx F., Metsemakers J.F., Roos S., Knottnerus J.A. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J. Clin. Epidemiol. 1998;(51):367—75. doi: 10.1016/s0895-4356(97)00306—5
  39. Abramov S.S., Goridovets E.V. Polymorbidity of internal pathology. Scientific notes of the educational institution Vitebsk Order of the Badge of Honor State Academy of Veterinary Medicine. [Uchenye zapiski uchrezhdenija obrazovanija Vitebskaja ordena Znak pocheta gosudarstvennaja akademija veterinarnoj mediciny]. 2010;46(1):165—167 (in Russian).
  40. Izmozherova N.V., Popov A.A., Kuryndina A.A., Gavrilova E.I., Shammatov M.A., Bakhtin V.M. Polymorbidity and polypragmasia in patients with high and very high cardiovascular risk. Rational pharmacotherapy in cardiology. [Racional'naja farmakoterapija v kardiologii]. 2022;18(1):20—26 (in Russian). doi: 10.20996/1819-6446-2022-02-09
  41. Dumbreck S., Flynn A., Nairn M., Wilson M., Treweek S., Mercer S.W., et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. J. BMJ. 2015;350:949. doi: 10.1136/bmj.h949
  42. Kaurov B.A., Matyukhina E.B. Features of the frequency spectrum of diseases and polymorbidity in the elderly and centenarians. Clinical gerontology. [Klinicheskaja gerontologija]. 2014;20(1—2):66—71 (in Russian).
  43. Smirnova E.N., Smirnova L.E., Shekhab L.H. Medical and social significance and pathogenetic mechanisms of comorbid course of chronic obstructive pulmonary disease and arterial hypertension. Verkhnevolzhsky Medical Journal. [Verhnevolzhskij medicinskij zhurnal]. 2016;4(15):26—31 (in Russian).

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2025 ФГБНУ Национальный НИИ Общественного здоровья имени Н.А. Семашко

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: r.bulletin@yandex.ru

Phone: +7 (495) 917-90-41 add. 136



Principal Contact

Kuzmina Uliia Aleksandrovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: r.bulletin@yandex.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies